HBOT — Hyperbaric Oxygen Therapy — has existed for decades. Its application in biological age reversal has not. The category is new, the language is unsettled, and the buyers fall into two non-overlapping shapes: clinics and individuals.
We were asked to act as the digital partner for the entire proposition. From category-definition to launch in the UAE, with one brand carrying both buyers.
The science is real but the proposition is unsettled. Pricing, terminology, expectations — none of it standardised. Differentiation has to land alongside Brian Johnson and the broader wellness conversation, without becoming wellness theatre.
Two audiences. B2B clinics for revenue today. B2C consumers for long-term brand equity.
We built a position around longevity-as-a-service that could carry to a clinical partner and to a consumer at the same time. The brand has to read as credible to a doctor and as desirable to a buyer.
We built the digital platform as the operating layer. Therapy tracking, booking, education for patients, clinicians, and affiliates — one product, three registers.
Investment decks, social strategy, conversion-first landing pages — built into the same brand spine. Pricing models, market segmentation, and parallel buyer messaging done as one piece of work, not stitched together later.
Content and operational workflow tuned for the UAE — aligning the digital experience with local regulation and the luxury wellness register the market expects.
The therapy gained traction post-launch with clinical partnerships and investor interest. The B2B and B2C halves work as one brand. The proposition entered the UAE as one of the first tech-enabled, protocol-driven longevity offerings with a complete digital presence.
